JLE

Néphrologie & Thérapeutique

MENU

Beta-blockers use from the general to the hemodialysis population Volume 15, issue 2, Avril 2019

Tables


  • Table 1

  • Table 2
Authors

1 IntroductionIt is no secret that chronic hemodialysis (HD) patients are at a high-risk for cardiovascular morbidity and mortality [1]. This makes the cardiologist the second most solicited specialist in the dialysis unit after the nephrologist. They are both challenged to prevent the early death of HD patients. However, what is clear and obvious for the general population seems to be inconstant and controversial in HD. Intermittent HD sessions, three times a week, expose the patients to a high [...]